Openers: CADTH CornerUncharted territory for those with schizophrenia. Depressed? Stick needles in your headAcupuncture promising as add-on therapy There’s an app for... problem gambling New tools aim to reduce or stop harmful activity through self-monitoring Physiotherapists, psychologists to prescribe in Australia MDs fear proposal jeopardizes patient safety Saphris: new atypical antipsychotic New drug indicated for treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar I disorder. Depressed heart patients recover more slowly from exercise Sympathetic dysregulation may help explain worse outcomes in these patients Champix may help reduce alcohol consumption Smoking-cessation drug varenicline (marketed as Champix in Canada) may have potential as a means of reducing alcohol consumption Clinical Notes: Guidelines for monitoring atypical antipsychotics in children Group issues three sets of recommendations concerning the monitoring and management of adverse effects. Mental Health Feature: Depression in youth Treatment, current controversies and the pharmacist’s role. ECT credentialling process planned for Canadian MDs Training would build on CPA workshop First Previous 52 53 54 55 56 Next Last
